Insmed Stock Jumps 28% on Experimental Hypertension Drug Trial Results
In This Article:
The company reports the results of a Phase 2b study for a drug meant to treat pulmonary arterial hypertension.
Oops, something went wrong
The company reports the results of a Phase 2b study for a drug meant to treat pulmonary arterial hypertension.